Trial Outcomes & Findings for Telephone Counseling and the Distribution of Nicotine Patches to Smokers (NCT NCT00851357)

NCT ID: NCT00851357

Last Updated: 2020-02-13

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

4200 participants

Primary outcome timeframe

7 months post enrollment

Results posted on

2020-02-13

Participant Flow

Participant milestones

Participant milestones
Measure
Usual Care
Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.
Patch (Placebo)
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.
Patch (Real)
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.
Overall Study
STARTED
1200
1201
1799
Overall Study
COMPLETED
1200
1201
1799
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Telephone Counseling and the Distribution of Nicotine Patches to Smokers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=1200 Participants
Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.
Patch (Placebo)
n=1201 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.
Patch (Real)
n=1799 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.
Total
n=4200 Participants
Total of all reporting groups
Age, Customized
18-24
136 Participants
n=5 Participants
145 Participants
n=7 Participants
205 Participants
n=5 Participants
486 Participants
n=4 Participants
Age, Customized
25-44
569 Participants
n=5 Participants
534 Participants
n=7 Participants
877 Participants
n=5 Participants
1980 Participants
n=4 Participants
Age, Customized
45-64
453 Participants
n=5 Participants
461 Participants
n=7 Participants
648 Participants
n=5 Participants
1562 Participants
n=4 Participants
Age, Customized
65+
40 Participants
n=5 Participants
61 Participants
n=7 Participants
68 Participants
n=5 Participants
169 Participants
n=4 Participants
Age, Customized
Unknown
2 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Sex: Female, Male
Female
658 Participants
n=5 Participants
645 Participants
n=7 Participants
998 Participants
n=5 Participants
2301 Participants
n=4 Participants
Sex: Female, Male
Male
542 Participants
n=5 Participants
556 Participants
n=7 Participants
801 Participants
n=5 Participants
1899 Participants
n=4 Participants
Race/Ethnicity, Customized
White
638 Participants
n=5 Participants
609 Participants
n=7 Participants
888 Participants
n=5 Participants
2135 Participants
n=4 Participants
Race/Ethnicity, Customized
Black
191 Participants
n=5 Participants
194 Participants
n=7 Participants
307 Participants
n=5 Participants
692 Participants
n=4 Participants
Race/Ethnicity, Customized
Hispanic
250 Participants
n=5 Participants
270 Participants
n=7 Participants
421 Participants
n=5 Participants
941 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian
24 Participants
n=5 Participants
36 Participants
n=7 Participants
46 Participants
n=5 Participants
106 Participants
n=4 Participants
Race/Ethnicity, Customized
American Indian
18 Participants
n=5 Participants
16 Participants
n=7 Participants
24 Participants
n=5 Participants
58 Participants
n=4 Participants
Race/Ethnicity, Customized
Multi-Race
76 Participants
n=5 Participants
73 Participants
n=7 Participants
103 Participants
n=5 Participants
252 Participants
n=4 Participants
Race/Ethnicity, Customized
Unknown
3 Participants
n=5 Participants
3 Participants
n=7 Participants
10 Participants
n=5 Participants
16 Participants
n=4 Participants
Education
<12
314 Participants
n=5 Participants
288 Participants
n=7 Participants
444 Participants
n=5 Participants
1046 Participants
n=4 Participants
Education
HS Diploma
405 Participants
n=5 Participants
378 Participants
n=7 Participants
595 Participants
n=5 Participants
1378 Participants
n=4 Participants
Education
Some College
396 Participants
n=5 Participants
442 Participants
n=7 Participants
631 Participants
n=5 Participants
1469 Participants
n=4 Participants
Education
BA/BS or Higher
84 Participants
n=5 Participants
92 Participants
n=7 Participants
128 Participants
n=5 Participants
304 Participants
n=4 Participants
Education
Unknown
1 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Language
English
1068 Participants
n=5 Participants
1049 Participants
n=7 Participants
1559 Participants
n=5 Participants
3676 Participants
n=4 Participants
Language
Spanish
132 Participants
n=5 Participants
152 Participants
n=7 Participants
240 Participants
n=5 Participants
524 Participants
n=4 Participants
Smoke Level
6-10
352 Participants
n=5 Participants
353 Participants
n=7 Participants
527 Participants
n=5 Participants
1232 Participants
n=4 Participants
Smoke Level
11+
848 Participants
n=5 Participants
848 Participants
n=7 Participants
1272 Participants
n=5 Participants
2968 Participants
n=4 Participants

PRIMARY outcome

Timeframe: 7 months post enrollment

Outcome measures

Outcome measures
Measure
Usual Care
n=1200 Participants
Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.
Patch (Placebo)
n=1201 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.
Patch (Real)
n=1799 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.
Number of Participants With Six-month Continuous Abstinence From Cigarettes
70 Participants
101 Participants
190 Participants

SECONDARY outcome

Timeframe: 2-months post enrollment

Outcome measures

Outcome measures
Measure
Usual Care
n=1200 Participants
Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.
Patch (Placebo)
n=1201 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.
Patch (Real)
n=1799 Participants
Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.
Number of Participants Quit for 30-days at 2-months Post Enrollment
136 Participants
173 Participants
334 Participants

Adverse Events

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patch (Placebo)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patch (Real)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Principal Investigator

UCSD

Phone: 858-300-1056

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place